What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Leukemia
Her scientific interests lie mostly in Internal medicine, Transplantation, Surgery, Gastroenterology and Hematopoietic stem cell transplantation.
Her Internal medicine study frequently links to adjacent areas such as Oncology.
The study incorporates disciplines such as Retrospective cohort study, Hematology, Immunology and Hazard ratio in addition to Transplantation.
Her Surgery research incorporates elements of Incidence and Risk factor.
Her research in Gastroenterology intersects with topics in Cord blood, Cyclophosphamide, Busulfan, Transplantation Conditioning and Acute lymphocytic leukemia.
Her Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Survival rate, Autoimmune disease, Clinical endpoint, Randomization and Pediatrics.
Her most cited work include:
- Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). (379 citations)
- Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party (344 citations)
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases (278 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Transplantation, Acute leukemia, Oncology and Hematopoietic stem cell transplantation.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Surgery.
Her research investigates the connection with Surgery and areas like Bone marrow which intersect with concerns in Haematopoiesis.
Her Transplantation study combines topics from a wide range of disciplines, such as Regimen, Cyclophosphamide, Cumulative incidence and Hazard ratio.
She combines subjects such as Busulfan, Marrow transplantation, Total body irradiation, Transplantation Conditioning and Cohort with her study of Acute leukemia.
Her Hematopoietic stem cell transplantation study combines topics in areas such as Survival rate, Retrospective cohort study, Immunology, Human leukocyte antigen and Pediatrics.
She most often published in these fields:
- Internal medicine (85.43%)
- Transplantation (71.92%)
- Acute leukemia (50.73%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (85.43%)
- Transplantation (71.92%)
- Oncology (38.94%)
In recent papers she was focusing on the following fields of study:
Myriam Labopin mainly focuses on Internal medicine, Transplantation, Oncology, Acute leukemia and Myeloid leukemia.
Her Internal medicine study frequently intersects with other fields, such as Gastroenterology.
The various areas that Myriam Labopin examines in her Transplantation study include Cumulative incidence, Disease, Retrospective cohort study and Hazard ratio.
Her work in Oncology addresses issues such as Cohort, which are connected to fields such as Cohort study.
Her studies deal with areas such as Minimal residual disease, Lymphoblastic Leukemia, Karnofsky Performance Status and Marrow transplantation as well as Acute leukemia.
Her Myeloid leukemia research incorporates themes from Regimen and Fludarabine.
Between 2018 and 2021, her most popular works were:
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. (65 citations)
- COVID-19 outcomes in patients with hematologic disease. (59 citations)
- Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis. (45 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Leukemia
Myriam Labopin mostly deals with Internal medicine, Transplantation, Oncology, Acute leukemia and Myeloid leukemia.
Her research in Hematopoietic stem cell transplantation, Leukemia, Cyclophosphamide, Incidence and Hazard ratio are components of Internal medicine.
Her study in the fields of Graft-versus-host disease under the domain of Transplantation overlaps with other disciplines such as Sibling.
Her Oncology research is multidisciplinary, relying on both Complete remission, Chemotherapy, Secondary Acute Myeloid Leukemia and Risk factor.
The concepts of her Acute leukemia study are interwoven with issues in Minimal residual disease, Total body irradiation and Marrow transplantation.
Her biological study spans a wide range of topics, including Regimen, Randomized controlled trial and Fludarabine, Treosulfan.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
